Biocytogen Pharmaceuticals (Beijing). (2315.HK) Q3 2024 Earnings

28AugConfirmed
Q4 2022
Q2 2023
Q1 2024
Q3 2024
-0.53
-0.4
-0.26
-0.13

Details

Expected EPS
-0.12875946144
Actual EPS
-0.13948941656000002
Surprise EPS
-0.01
Surprise Percent
+8.33%

Description

Biocytogen Pharmaceuticals (Beijing). (2315.HK) has reported earnings of -0.13948941656000002 per share for Q3 2024.

0 Comments

Share your thoughts